Background
A proliferation-inducing ligand (APRIL) is implicated in the pathogenesis of IgA nephropathy. Sibeprenlimab is a humanized IgG2 monoclonal antibody that binds to and neutralizes APRIL.Methods
In this phase 2, multicenter, double-blind, randomized, placebo-controlled, paral...
